Up a level |
2021
Kong, Fan-En, Li, Guang-Meng, Tang, Yun-Qiang, Xi, Shao-Yan, Loong, Jane Ho Chun, Li, Mei-Mei, Li, Hao-Long, Cheng, Wei ORCID: 0000-0002-0088-7209, Zhu, Wen-Jie, Mo, Jia-Qiang, Gong, Yuan-Feng, Tang, Hui, Zhao, Yue, Zhang, Yan, Ma, Stephanie, Guan, Xin-Yuan, Ma, Ning-Fang, Xie, Mao-Bin and Liu, Ming (2021). Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. Sci. Transl. Med., 13 (579). WASHINGTON: AMER ASSOC ADVANCEMENT SCIENCE. ISSN 1946-6242
Yang, Xiao-Dong, Kong, Fan-En, Qi, Ling, Lin, Jia-Xin, Yan, Qian, Loong, Jane Ho Chun, Xi, Shao-Yan, Zhao, Yue, Zhang, Yan, Yuan, Yun-Fei, Ma, Ning-Fang, Ma, Stephanie, Guan, Xin-Yuan and Liu, Ming (2021). PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma. Mol. Cancer, 20 (1). LONDON: BMC. ISSN 1476-4598